First Eagle Investment Management
BBNX

First Eagle Investment Management’s Beta Bionics BBNX Stock Holding History

First Eagle Investment Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Sell
242,000
-11,702
-5% -$173K ﹤0.01% 313
2025
Q4 		$7.73M Buy
253,702
+20,500
+9% +$547K 0.01% 203
2025
Q3 		$4.63M Buy
+233,202
New +$4.1M 0.01% 262

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

First Eagle Investment Management's BBNX Position: Q1 2026 in Review

First Eagle Investment Management reduced its Beta Bionics (BBNX) stake by 4.6% in Q1 2026, selling an estimated $173K and leaving 242,000 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #313.

First Eagle Investment Management first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.73M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • First Eagle Investment Management held 242,000 shares of Beta Bionics worth $2.42M as of Q1 2026.
  • First Eagle Investment Management sold 11,702 Beta Bionics shares in Q1 2026, an estimated $173K.
  • Beta Bionics made up ﹤0.01% of First Eagle Investment Management's portfolio in Q1 2026, its #313 holding.
  • First Eagle Investment Management first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • First Eagle Investment Management's Beta Bionics position peaked at $7.73M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on First Eagle Investment Management's 13F filing for Q1 2026, filed 12 May 2026.